Meronem Iv

Meropenem, the active ingredient in Meronem Iv, is a carbapenem antibiotic presented as an intravenous solution for intravenous use. It treats severe bacterial infections such as intra‑abdominal sepsis, urinary tract infections, pneumonia, meningitis and septicemia in hospitalized patients.

GNH USA supplies Meronem Iv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meronem Iv is a broad‑spectrum carbapenem used to treat serious bacterial infections in the hospital setting.

Complicated intra‑abdominal infection: provides rapid bacterial eradication in patients with intra‑abdominal sepsis. Complicated urinary tract infection: clears resistant uropathogens causing pyelonephritis. Hospital‑acquired pneumonia: effective against multidrug‑resistant organisms in ventilated patients. Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis. Septicemia: achieves systemic bacterial clearance in bloodstream infections.

Adverse reactions may occur with any intravenous antibiotic. Monitoring is recommended during therapy.

Common Side Effects: - Nausea - Diarrhea - Headache - Rash or pruritus at infusion site - Phlebitis or infusion site pain - Elevated liver enzymes

Serious or Rare Side Effects: - Seizures, especially in patients with renal impairment or CNS disease - Clostridioides difficile‑associated colitis - Anaphylactic or severe allergic reactions - Neutropenia or agranulocytosis - Acute renal failure - Severe electrolyte disturbances

Meronem Iv requires careful clinical assessment before and during therapy. - Renal impairment: adjust dose based on creatinine clearance. - CNS disorders: monitor for seizures, especially in patients with a history of epilepsy. - Hypersensitivity: avoid in patients with known carbapenem or β‑lactam allergy. - Concomitant antibiotics: assess for additive nephrotoxicity. - C. difficile risk: monitor for signs of colitis during and after treatment. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meronem Iv can alter the pharmacokinetics of several drugs.

Major Interactions (Avoid): - Valproic acid: reduced serum levels, risk of seizure breakthrough. - Oral contraceptives: decreased efficacy, consider alternative contraception. - Probenecid: increased meropenem concentrations, heightened toxicity risk. - Aminoglycosides: additive nephrotoxicity. - Loop diuretics: enhanced renal adverse effects.

Moderate Interactions (Monitor Closely): - Warfarin: possible INR elevation, monitor coagulation. - Phenytoin: altered antiepileptic levels, check serum concentrations. - NSAIDs: increased risk of renal impairment. - Rifampicin: potential reduction in meropenem exposure. - Immunosuppressants: monitor for infection risk.